FDA inspection
CSPC-NBP Pharmaceutical Co., Ltd.: FDA inspection ending Nov 9, 2018
FDA inspection 1073726 · No Action Indicated (NAI) · Shijiazhuang
Key facts
| Inspection ID | 1073726 |
|---|---|
| Firm | CSPC-NBP Pharmaceutical Co., Ltd. |
| FEI number | 3007221763 |
| Address | 88 Yangzi Road, Economic &Technological Development Zone |
| City | Shijiazhuang |
| Fiscal year | 2019 |
| Inspection end date | Nov 9, 2018 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data